Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01286337
Other study ID # ligasure
Secondary ID ligamonza
Status Completed
Phase Phase 3
First received January 19, 2011
Last updated January 28, 2011
Start date April 2009
Est. completion date January 2011

Study information

Verified date August 2010
Source University of Milano Bicocca
Contact n/a
Is FDA regulated No
Health authority Italy: Ministry of Health
Study type Interventional

Clinical Trial Summary

lymphorrehea remains the most frequent complication after axillary lymphadenectomy. we hyphothesize that the use of a bipolar vessel sealing may reduce the rate of lymph collection compared to the traditional surgical technique


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date January 2011
Est. primary completion date March 2010
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Women with documented breast cancer (by histology or cytology) and candidate to elective axillary lymphadenectomy

Exclusion Criteria:

- Age less than 18 years

- Denied written informed content

- Previous axillary operations (except for sentinel node biopsy)

- Preoperative radio-chemotherapy

- Scheduled reconstructive breast operation

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
bipolar vessel sealing

control


Locations

Country Name City State
Italy San Gerardo Hospital Monza

Sponsors (1)

Lead Sponsor Collaborator
University of Milano Bicocca

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary reduction of lymphorrhea rate forth postoperative day No
Secondary reduction of lymph output from the axillary drain forth postoperative days No